Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.3.0.814
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenue:        
Product revenues $ 0 $ 3,000 $ 0 $ 28,000
License revenues 0 0 27,000 0
TOTAL REVENUE 0 3,000 27,000 28,000
Cost of Product Revenue 0 5,000 0 22,000
Gross profit 0 (2,000) 27,000 6,000
Operating Expenses:        
Research and development 225,000 0 475,000 0
Selling, general and administrative expenses 2,552,000 547,000 5,571,000 760,000
Total operating expenses 2,777,000 547,000 6,046,000 760,000
Loss from Operations (2,777,000) (549,000) (6,019,000) (754,000)
Other income (expense)        
Change in value of warrant and derivative liabilities 2,809,000 (407,000) 20,683,000 (468,000)
Interest expense (1,724,000) (3,263,000) (10,012,000) (3,628,000)
Total Other Income (Expense) 1,085,000 (3,670,000) 10,671,000 (4,096,000)
Income/(loss) before minority interest and provision for income taxes (1,692,000) (4,219,000) 4,652,000 (4,850,000)
Plus: net (income) loss attributable to the noncontrolling interest 0 (1,000) 0 (3,000)
Income/(loss) before provision for income taxes (1,692,000) (4,220,000) 4,652,000 (4,853,000)
Provision for income taxes 0 0 0 0
Net income/(loss) $ (1,692,000) $ (4,220,000) $ 4,652,000 $ (4,853,000)
Weighted Average Common Shares Outstanding - Basic 600,000,000 590,055,554 598,170,683 578,719,524
Weighted Average Common Shares Outstanding - Diluted 600,000,000 590,055,554 1,191,188,371 578,719,524
Income (loss) per share - Basic $ (0.00) $ (0.01) $ 0.01 $ (0.01)
Income (loss) per share - Diluted $ (0.00) $ (0.01) $ 0.00 $ (0.01)